Neobiosis Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Neobiosis's estimated annual revenue is currently $1.9M per year.(i)
  • Neobiosis's estimated revenue per employee is $97,895

Employee Data

  • Neobiosis has 19 Employees.(i)
  • Neobiosis grew their employee count by 90% last year.

Neobiosis's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Director Laboratory OperationsReveal Email/Phone
3
Director ManufacturingReveal Email/Phone
4
Director AdministrationReveal Email/Phone
5
Manager Partner DevelopmentReveal Email/Phone
6
Account CoordinatorReveal Email/Phone
7
Manufacturing Technician IIReveal Email/Phone
8
Manufacturing Technician 2Reveal Email/Phone
9
Quality Control SpecialistReveal Email/Phone
10
Legal LiaisonReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M9315%N/AN/A
#2
N/A100%N/AN/A
#3
$1.1M60%N/AN/A
#4
$3.7M2420%N/AN/A
#5
$4.3M259%N/AN/A
#6
$2.5M16N/AN/AN/A
#7
$0.8M40%N/AN/A
#8
$1.1M60%N/AN/A
#9
$2.5M148%N/AN/A
#10
$1.4M3-57%N/AN/A
Add Company

What Is Neobiosis?

Neobiosis, LLC is a privately owned biomedical contract development and manufacturing organization (CDMO) with two production facilities in downtown Gainesville and a Research & Development laboratory located within the Sid Martin UF Innovate biotechnology Institute in Alachua, FL. The focus of Neobiosis is the isolation of tissues, cells and extracellular vesicles (EVs), with medicinal potential, from donated perinatal (birth) tissues, including umbilical cord, umbilical cord blood and amniotic fluid. The name Neobiosis ("new life") is derived from a series of experiments called Parabiosis ("living together") where it was discovered that tissues, cells and EVs from a young donor could be used to promote the healing of older individuals. Neobiosis produces innovative products from healthy, full-term births, for client organizations who wish to take biomedical products though FDA-approved clinical trials for commercialization in a global market. Neobiosis is also committed to advancing an in-house pipeline of intellectual property and biological medicines.

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1.9M

Revenue (est)

90%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.7M190%N/A
#2
$15M19N/AN/A
#3
$5.9M19-17%N/A
#4
N/A19-14%N/A
#5
$1.7M19-21%N/A